Treatment of type 2 diabetes with combined therapy: what are the pros and cons?
about
Initiating insulin therapy in type 2 diabetic patients failing on oral hypoglycemic agents: basal or prandial insulin? The APOLLO trial and beyond.Improvements in quality of life associated with biphasic insulin aspart 30 in type 2 diabetes patients in China: results from the A1chieve® observational studyAntiobesity and hypoglycaemic effects of aqueous extract of Ibervillea sonorae in mice fed a high-fat diet with fructose.C-peptide prevents hyperglycemia-induced endothelial apoptosis through inhibition of reactive oxygen species-mediated transglutaminase 2 activationIntensification of insulin therapy in patients with type 2 diabetes: a retrospective, non- interventional cohort study of patients treated with insulin glargine or biphasic human insulin in daily clinical practiceC-peptide activates AMPKα and prevents ROS-mediated mitochondrial fission and endothelial apoptosis in diabetes.Complementing insulin therapy to achieve glycemic control.Efficacy and safety of tofogliflozin in Japanese patients with type 2 diabetes mellitus with inadequate glycaemic control on insulin therapy (J-STEP/INS): Results of a 16-week randomized, double-blind, placebo-controlled multicentre trial.Dual effects of sodium tungstate on adipocyte biology: inhibition of adipogenesis and stimulation of cellular oxygen consumption.Prevention of VEGF-mediated microvascular permeability by C-peptide in diabetic mice.Insulin therapy for type 2 diabetes
P2860
Q33610830-F2E66990-439E-42AC-8CAC-44670D2E1D26Q34622183-DD216C1C-2800-4C02-AA01-B493BD37AEF8Q35586250-DEF594F0-CE7C-4EA1-A97D-DB13C622620CQ36477346-7A54C378-0D2C-4A09-BEC4-798FD3714227Q37113227-A4CC1C77-93CB-4756-8DBF-7CA7F622B948Q37251110-246B6F62-0F68-4C27-8B61-57C1596053C8Q38116766-B31FFBB9-7987-4E36-B4E6-EB5826ACAB59Q40266818-C73A1F6F-7C40-4CBD-9038-1DC27B7C0A7CQ42802560-0D4264E0-84B5-4CD6-B72B-D33543CE1375Q45993671-35217973-AE35-4884-A9F9-7E7BCC9EC6BDQ58886197-627A625F-A2E0-41B4-BF96-D34CAD0DAE98
P2860
Treatment of type 2 diabetes with combined therapy: what are the pros and cons?
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on February 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Treatment of type 2 diabetes with combined therapy: what are the pros and cons?
@en
Treatment of type 2 diabetes with combined therapy: what are the pros and cons?
@nl
type
label
Treatment of type 2 diabetes with combined therapy: what are the pros and cons?
@en
Treatment of type 2 diabetes with combined therapy: what are the pros and cons?
@nl
prefLabel
Treatment of type 2 diabetes with combined therapy: what are the pros and cons?
@en
Treatment of type 2 diabetes with combined therapy: what are the pros and cons?
@nl
P356
P1433
P1476
Treatment of type 2 diabetes with combined therapy: what are the pros and cons?
@en
P2093
Marco Orsini-Federici
Massimo Massi-Benedetti
P304
P356
10.2337/DC08-S233
P407
P478
31 Suppl 2
P577
2008-02-01T00:00:00Z